en POLSKI
eISSN: 2083-8441
ISSN: 2081-237X
Pediatric Endocrinology Diabetes and Metabolism
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
3/2023
vol. 29
 
Share:
Share:
abstract:
Review paper

Glucose management indicator – potential factors affecting differences in comparison with HbA1c and clinical significance of this phenomenon

Łukasz Wybrańczyk
1
,
Aleksandra Brudzińska
1
,
Przemysława Jarosz-Chobot
2
,
Grażyna Deja
2

  1. Students' Scientific Association in the Department of Children's Diabetology, Medical University of Silesia, Katowice, Poland
  2. Department of Children's Diabetology, Medical University of Silesia, Katowice, Poland
Pediatr Endocrinol Diabetes Metab 2023; 29 (3): 190-195
Online publish date: 2023/09/15
View full text Get citation
 
PlumX metrics:
HbA1c and the glucose management indicator (GMI) are now widely recognized as the gold standard for assessing the effectiveness of diabetes therapy. The GMI is a result of a mathematical formula used to estimate HbA1c with continuous glucose monitoring (CGM) data in patients with diabetes. It is a useful parameter providing a good estimate of CGM metrics for a 3-month period with just 10–14 days of data. It can reflect the effectiveness of administered/modified therapy of insulin faster than traditional measurements of laboratory HbA1c and can be used as an educational tool and in telemedicine. Unfortunately, there are significant discordances between GMI and laboratory-measured HbA1c, reaching as much as 0.5–1% in many patients. It may be caused by well-known factors influencing HbA1c measurement and red blood cell turnover like anaemia, haemoglobinopathies, or certain medications, but these causes of potential errors are too rare in everyday practice to account for the amount of discrepancy reported in the literature.

In this article we would like to review other new potential factors that may influence HbA1c estimation based on GMI and cause potential differences between results calculated from CGM and those measured in the laboratory. In addition, we will present clinical implications of the observed differences between GMI and HbA1c. Recognizing the factors that cause such differences is an important clinical skill. Moreover, understanding the principles of evaluating paired measures of these parameters will allow us to individualize the treatment of each person with diabetes.
keywords:

diabetes, HbA1c, GMI, CGM


Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.